We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genomic Sequencing Cos. Face FTC Scrutiny On $1B Deal

Law360 (January 4, 2019, 5:52 PM EST) -- DNA-sequencing company Illumina Inc.'s $1.2 billion bid to purchase genetic sequencing systems firm Pacific Biosciences of California Inc. is drawing extra scrutiny from the Federal Trade Commission.

PacBio said Thursday in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.